{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T13:15:05Z","timestamp":1782393305484,"version":"3.54.5"},"reference-count":48,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"unspecified","delay-in-days":30,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Ministerio de Ciencia, Tecnolog\u00eda e Innovaci\u00f3n (MinCiencias), Colombia","award":["906-2021"],"award-info":[{"award-number":["906-2021"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To identify preconception clinical factors associated with adverse pregnancy outcomes (APO) in patients with systemic lupus erythematosus (SLE) or primary Sj\u00f6gren\u2019s syndrome (pSS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A single-centre, retrospective cohort study was conducted, which included pregnant women treated at the University Medical Center Groningen between January 2010 and August 2021 who fulfilled classification criteria for SLE or pSS. Demographic data, relevant comorbidities, disease duration, disease activity before and during pregnancy, APO, laboratory parameters and treatment regimens were recorded. Associations between the presence of APO and preconception characteristics were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our study population included 48 (70%) SLE and 21 (30%) pSS pregnancies concerning 70 fetuses (one twin). Preterm birth (n=9, 19%) was the most frequent APO in SLE pregnancies, while in pSS pregnancies this was miscarriages (n=3, 14%). There were no associations between the presence of APO in SLE pregnancies and clinical parameters, laboratory parameters or medication use prior to conception. In the pSS group, significant associations were found between the presence of APO and body mass index (p=0.010), parity (p=0.046), C4 (p=0.021) and low C4 levels (p=0.002).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>No preconception risk factors related to APO were found in SLE pregnancies, whereas preconception complement levels were associated with APO development in patients with pSS.<\/jats:p><\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003439","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T16:44:26Z","timestamp":1693500266000},"page":"e003439","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Preconception clinical factors related to adverse pregnancy outcomes in patients with systemic lupus erythematosus or primary Sj\u00f6gren\u2019s syndrome: a retrospective cohort study"],"prefix":"10.1136","volume":"9","author":[{"given":"Juan J.","family":"Fierro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelmer R.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenny M.","family":"Verstappen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrika","family":"Bootsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Westra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0218-9364","authenticated-orcid":false,"given":"Karina","family":"de Leeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"2023083108501620000_9.3.e003439.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.02.009"},{"key":"2023083108501620000_9.3.e003439.2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1515\/jpm-2019-0034","article-title":"Effect of Sjogren\u2019s syndrome on maternal and neonatal outcomes of pregnancy","volume":"47","author":"Elliott","year":"2019","journal-title":"J Perinat Med"},{"key":"2023083108501620000_9.3.e003439.3"},{"key":"2023083108501620000_9.3.e003439.4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar3227","article-title":"Managing pregnancy in inflammatory Rheumatological diseases","volume":"13","author":"Jain","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2023083108501620000_9.3.e003439.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30546-X"},{"key":"2023083108501620000_9.3.e003439.6","doi-asserted-by":"crossref","unstructured":"Buyon JP , Kim MY , Salmon JE . Predictors of pregnancy outcomes in patients with lupus. Ann Intern Med 2016;164:131. doi:10.7326\/L15-0500","DOI":"10.7326\/L15-0500"},{"key":"2023083108501620000_9.3.e003439.7","doi-asserted-by":"crossref","unstructured":"Kroese SJ , Abheiden CNH , Blomjous BS , et al . Maternal and perinatal outcome in women with systemic lupus erythematosus: A retrospective Bicenter cohort study. J Immunol Res 2017;2017:8245879. doi:10.1155\/2017\/8245879","DOI":"10.1155\/2017\/8245879"},{"key":"2023083108501620000_9.3.e003439.8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"2023083108501620000_9.3.e003439.9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2016.10.004","article-title":"The Antiphospholipid syndrome in patients with systemic lupus erythematosus","volume":"76","author":"Pons-Estel","year":"2017","journal-title":"J Autoimmun"},{"key":"2023083108501620000_9.3.e003439.10","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/keaa203","article-title":"EUREKA algorithm predicts obstetric risk and response to treatment in women with different Subsets of anti-phospholipid antibodies","volume":"60","author":"Pregnolato","year":"2021","journal-title":"Rheumatology"},{"key":"2023083108501620000_9.3.e003439.11","doi-asserted-by":"crossref","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","article-title":"Sj\u00f6gren syndrome","volume":"2","author":"Brito-Zer\u00f3n","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2023083108501620000_9.3.e003439.12","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s10067-016-3323-9","article-title":"Association between primary Sjogren\u2019s syndrome and pregnancy complications: a systematic review and meta-analysis","volume":"35","author":"Upala","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2023083108501620000_9.3.e003439.13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.autrev.2013.09.003","article-title":"The impact of primary Sjogren's syndrome on pregnancy outcome: our series and review of the literature","volume":"13","author":"De Carolis","year":"2014","journal-title":"Autoimmun Rev"},{"key":"2023083108501620000_9.3.e003439.14","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121518"},{"key":"2023083108501620000_9.3.e003439.15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209770"},{"key":"2023083108501620000_9.3.e003439.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"2023083108501620000_9.3.e003439.17","doi-asserted-by":"crossref","unstructured":"Hochberg MC . Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725. doi:10.1002\/art.1780400928","DOI":"10.1002\/art.1780400928"},{"key":"2023083108501620000_9.3.e003439.18","doi-asserted-by":"publisher","DOI":"10.1002\/art.34473"},{"key":"2023083108501620000_9.3.e003439.19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"American college of rheumatology\/European League against rheumatism classification criteria for primary Sjogren\u2019s syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023083108501620000_9.3.e003439.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2023083108501620000_9.3.e003439.21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218356"},{"key":"2023083108501620000_9.3.e003439.22","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350606"},{"key":"2023083108501620000_9.3.e003439.23","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.110619"},{"key":"2023083108501620000_9.3.e003439.24","doi-asserted-by":"crossref","unstructured":"Seror R , Bowman SJ , Brito-Zeron P , et al . EULAR Sj\u00f6gren\u2019s syndrome disease activity index (ESSDAI): a user guide. RMD Open 2015;1:e000022. doi:10.1136\/rmdopen-2014-000022","DOI":"10.1136\/rmdopen-2014-000022"},{"key":"2023083108501620000_9.3.e003439.25","doi-asserted-by":"publisher","DOI":"10.1002\/uog.15884"},{"key":"2023083108501620000_9.3.e003439.26","unstructured":"Gestational Hypertension and Preeclampsia . ACOG practice Bulletin, number 222. Obstet Gynecol. 2020. Available: https:\/\/journals.lww.com\/greenjournal\/Fulltext\/2020\/06000\/Gestational_Hypertension_and_Preeclampsia__ACOG.46.aspx"},{"key":"2023083108501620000_9.3.e003439.27","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213"},{"key":"2023083108501620000_9.3.e003439.28","doi-asserted-by":"crossref","unstructured":"Ravelli ACJ , Eskes M , van der Post JAM , et al . Decreasing trend in Preterm birth and perinatal mortality, do disparities also decline BMC Public Health 2020;20:783. doi:10.1186\/s12889-020-08925-w","DOI":"10.1186\/s12889-020-08925-w"},{"key":"2023083108501620000_9.3.e003439.29","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000194205.95870.86"},{"key":"2023083108501620000_9.3.e003439.30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bpobgyn.2019.09.002","article-title":"Pregnancy and systemic lupus erythematosus","volume":"64","author":"Petri","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2023083108501620000_9.3.e003439.31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ajog.2015.09.066","article-title":"Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and Antiphospholipid antibodies: results of the PROMISSE study","volume":"214","author":"Kim","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2023083108501620000_9.3.e003439.32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jri.2018.04.002","article-title":"Angiogenic factors in pregnancies of women with Antiphospholipid syndrome and systemic lupus erythematosus","volume":"127","author":"Mayer-Pickel","year":"2018","journal-title":"J Reprod Immunol"},{"key":"2023083108501620000_9.3.e003439.33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/AOG.0000000000002504","article-title":"Risk of adverse pregnancy outcomes at advanced maternal age","volume":"131","author":"Frederiksen","year":"2018","journal-title":"Obstet Gynecol"},{"key":"2023083108501620000_9.3.e003439.34","doi-asserted-by":"publisher","DOI":"10.1136\/jech.2009.095406"},{"key":"2023083108501620000_9.3.e003439.35","doi-asserted-by":"crossref","unstructured":"Mankee A , Petri M , Magder LS . Lupus anticoagulant, disease activity and low complement in the first trimester are predictive of pregnancy loss. Lupus Sci Med 2015;2:e000095. doi:10.1136\/lupus-2015-000095","DOI":"10.1136\/lupus-2015-000095"},{"key":"2023083108501620000_9.3.e003439.36","doi-asserted-by":"crossref","unstructured":"Hiramatsu Y , Isoda K , Kotani T , et al . Pre-pregnancy serum complement C3 level is a Predictor of Preterm birth for pregnancies with systemic lupus erythematosus. Arthritis Res Ther 2021;23:140. doi:10.1186\/s13075-021-02522-x","DOI":"10.1186\/s13075-021-02522-x"},{"key":"2023083108501620000_9.3.e003439.37","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202449"},{"key":"2023083108501620000_9.3.e003439.38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0897.1992.tb00787.x"},{"key":"2023083108501620000_9.3.e003439.39","doi-asserted-by":"crossref","unstructured":"Crisafulli F , Andreoli L , Zucchi D , et al . Variations of C3 and C4 before and during pregnancy in systemic lupus erythematosus: association with disease flares and obstetric outcomes. J Rheumatol 2023:jrheum. doi:10.3899\/jrheum.2022-1135","DOI":"10.3899\/jrheum.2022-1135"},{"key":"2023083108501620000_9.3.e003439.40","doi-asserted-by":"crossref","unstructured":"Fierro JJ , Vel\u00e1squez M , Cadavid AP , et al . Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in Antiphospholipid syndrome. Am J Reprod Immunol 2022;87:e13509. doi:10.1111\/aji.13509","DOI":"10.1111\/aji.13509"},{"key":"2023083108501620000_9.3.e003439.41","doi-asserted-by":"crossref","first-page":"102524","DOI":"10.1016\/j.jaut.2020.102524","article-title":"Antiphospholipid autoantibody detection is important in all patients with systemic autoimmune diseases","volume":"115","author":"Marziale","year":"2020","journal-title":"J Autoimmun"},{"key":"2023083108501620000_9.3.e003439.42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212224"},{"key":"2023083108501620000_9.3.e003439.43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.6.643"},{"key":"2023083108501620000_9.3.e003439.44","doi-asserted-by":"crossref","unstructured":"Roubertou Y , Mainbourg S , Hot A , et al . Cryoglobulinemia in systemic lupus erythematosus: a retrospective study of 213 patients. Arthritis Res Ther 2022;24:167. doi:10.1186\/s13075-022-02857-z","DOI":"10.1186\/s13075-022-02857-z"},{"key":"2023083108501620000_9.3.e003439.45","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2015.29"},{"key":"2023083108501620000_9.3.e003439.46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.089268"},{"key":"2023083108501620000_9.3.e003439.47","doi-asserted-by":"crossref","unstructured":"Balevic SJ , Weiner D , Clowse MEB , et al . Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomes. Lupus Sci Med 2022;9:e000602. doi:10.1136\/lupus-2021-000602","DOI":"10.1136\/lupus-2021-000602"},{"key":"2023083108501620000_9.3.e003439.48","doi-asserted-by":"crossref","first-page":"693796","DOI":"10.3389\/fphar.2021.693796","article-title":"The efficiency of hydroxychloroquine for the treatment of primary Sj\u00f6gren\u2019s syndrome: A systematic review and meta-analysis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T16:44:37Z","timestamp":1693500277000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,8,31]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/rmdopen-2023-003439"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003439","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}